The role of microbiota in esophageal squamous cell carcinoma: A review of the literature

In conclusion, esophageal dysbiosis is associated with ESCC progression and chemoresistance. Screening the oral and esophageal microbiota is a potential diagnostic tool for predicting ESCC development or drug-resistance. Repairing esophageal dysbiosis is a novel treatment for ESCC. Clinical trials with probiotics in addition to current chemotherapy are warranted to study the therapeutic effects.
Source: Thoracic Cancer - Category: Cancer & Oncology Authors: Tags: REVIEW Source Type: research